Trials / Unknown
UnknownNCT04388735
Multiple Myeloma (MM) Quality of Life (QOL) Study
Quality of Life and Psychological Distress in Patients With Multiple Myeloma and Their Caregivers
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 360 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The main purpose of this study is to examine differences in quality of life and psychological distress for both Multiple Myeloma patients receiving treatment and their caregivers and to assess patient and caregiver prognostic understanding (understanding of the likely course of a disease over time) of Multiple Myeloma to guide development of more personalized treatment plans. This study looks to further understand quality of life changes throughout multiple myeloma therapy for both patients and caregivers to help determine ways to improve patient and caregiver understanding of illness and in turn, tailor customized treatment that best aligns with patient preferences. The study will use a series of questionnaires to measure quality of life, mood, coping strategies, and prognostic understanding.
Detailed description
This research study's procedures include screening for eligibility, participant designation of a caregiver and a series of questionnaires. \- It is expected that about 180 people undergoing treatment for multiple myeloma and up to 180 of their caregivers will take part in this research study. \-- The questionnaires are completed one time only and measure quality of life, mood, coping strategies, and prognostic understanding and can be completed in the hospital, clinic, over the email, or telephone with assistance provided as needed.Questionnaires take approximately 20 minutes to complete.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Questionnaire | Series of questions covering quality of life, physical and psychological symptom burden, mood, and illness and prognostic understanding administered in person or remotely. |
Timeline
- Start date
- 2020-06-01
- Primary completion
- 2021-11-15
- Completion
- 2022-05-16
- First posted
- 2020-05-14
- Last updated
- 2020-05-14
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04388735. Inclusion in this directory is not an endorsement.